Neurocrine Biosciences, Inc.
597 articles about Neurocrine Biosciences, Inc.
-
Neurocrine Biosciences, Inc. Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results
7/22/2011
-
Neurocrine Biosciences, Inc. Announces Notice of Allowance for Composition of Matter Patent on VMAT2 Inhibitor
6/23/2011
-
Neurocrine Biosciences, Inc. Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis
6/16/2011
-
Neurocrine Biosciences, Inc. to Ring The NASDAQ Stock Market Opening Bell
6/7/2011
-
Neurocrine Biosciences, Inc. to Present at the Jefferies and Co. 2011 Global Healthcare Conference
6/1/2011
-
Neurocrine Biosciences, Inc. Reports First Quarter 2011 Results
5/4/2011
-
Neurocrine Biosciences, Inc. Announces Conference Call and Webcast to Present First Quarter 2011 Financial Results
5/2/2011
-
Neurocrine Biosciences, Inc. to Present at the Deutsche Bank 36th Annual Healthcare Conference
4/28/2011
-
Neurocrine Biosciences, Inc. Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor
4/5/2011
-
Neurocrine Biosciences, Inc. to Present at the Roth 23rd Annual OC Growth Stock Conference
3/9/2011
-
Neurocrine Biosciences, Inc. to Present at the Cowen and Company 31st Annual Health Care Conference
3/3/2011
-
Neurocrine Biosciences, Inc. to Present at Citi's 2011 Global Health Care Conference
2/23/2011
-
Neurocrine Biosciences, Inc. Reports Fourth Quarter and Year End 2010 Results
2/11/2011
-
Neurocrine Biosciences, Inc. Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2010 Financial Results
2/10/2011
-
Neurocrine Biosciences, Inc. Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2010 Financial Results
2/4/2011
-
Neurocrine Biosciences, Inc. to Present at the 22nd Annual Piper Jaffray Health Care Conference
11/24/2010
-
Neurocrine Biosciences, Inc. Announces Successful Completion of Daisy PETAL Study
11/22/2010
-
Neurocrine Biosciences, Inc. Reports Third Quarter 2010 Results
10/29/2010
-
Neurocrine Biosciences, Inc. to Present at the Oppenheimer 21st Annual Healthcare Conference
10/27/2010
-
Neurocrine Biosciences, Inc. Announces Conference Call and Webcast to Report Third Quarter 2010 Financial Results
10/19/2010